首页 › 基金 › Venrock Adviser, LLC › SVRA

Venrock Adviser, LLC 对 SVRA 的持仓历史

SAVARA INC · 医疗保健

Venrock Adviser, LLC 在 Q3 2026 的 13F 申报中披露持有 SVRA(SAVARA INC)19,568,534 股,市值约 US$101.0M,约占其申报组合的 4.91%,在其申报持仓中市值排名第 5 位。 Venrock Adviser, LLC 最近 13 个申报季度中有 9 个季度披露了 SVRA 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)19.57M 股
申报持仓市值$100.97M
组合权重4.91%
首次申报Q3 2023
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Venrock Adviser, LLC 对 SVRA 的持仓演变

Venrock Adviser, LLC 于 Q3 2023 首次披露 SVRA 持仓:7,184,865 股(约 US$27.2M)。 该持仓在 Q3 2026 达到峰值 19,568,534 股,市值约 US$101.0M。 在 9 次申报中,Venrock Adviser, LLC 5 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 19,568,534 股、市值约 US$101.0M,环比增持 4,822,591 股。。 持仓曾出现大幅变动:Q4 2023 减持约 51% (随后一个季度股价上涨 6%)、Q2 2025 增持约 173% (随后一个季度股价上涨 57%)、Q3 2025 增持约 43% (随后一个季度股价上涨 69%)。

逐季持仓明细

季度股数金额变化
Q3 2023 7.18M $27.16M 新进
Q4 2023 3.50M $16.45M 减持
Q1 2025 3.26M $9.02M 新进
Q2 2025 8.88M $20.26M 增持
Q3 2025 12.68M $45.27M 增持
Q4 2025 13.74M $82.85M 增持
Q1 2026 13.74M $75.02M 持有
Q2 2026 14.75M $90.84M 增持
Q3 2026 19.57M $100.97M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SVRA 与 13F 数据

SVRA(SAVARA INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 SVRA,申报仓位最大的包括:NEA Management Company, LLC (US$126.3M), Bain Capital Life Sciences Investors, LLC (US$90.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$70.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SVRA 的基金

查看 SVRA 的全部基金持有人 →

常见问题

How long has Venrock Adviser, LLC held SVRA?

Venrock Adviser, LLC has disclosed SVRA holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is Venrock Adviser, LLC's current position in SVRA?

As of Q3 2026, Venrock Adviser, LLC holds 19.57M shares of SVRA (SAVARA INC), valued at $100.97M, representing 4.91% of its reported portfolio and ranking #5.

Has Venrock Adviser, LLC been buying or selling SVRA?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC increased its position in SVRA. The position peaked in Q3 2026 at 19.57M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.